Clinical Trials Projects

SMA Europe is playing a key part in the successful introduction of clinical trials across Europe. The translation of scientific advances into effective therapies is made more difficult by issues such as the complex regulatory environment in Europe, variations in standards of care, patient enrolment, a narrow therapeutic window and a need for more sensitive biomarkers and outcome measures.

The current SMA drug pipeline includes 7 potential therapies in clinical trials:

 More information